News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Philip Philip, MD

Articles by Philip Philip, MD

Phillip Phillip, MD

Dr Philip on Considerations for Selecting First-Line Treatment in Newly Diagnosed, Low-Risk GI NETs

ByPhilip Philip, MD

January 16th 2025

Philip Philip, MD, discusses considerations for selecting first-line treatment for newly diagnosed, low-risk gastrointestinal neuroendocrine tumors.

Latest Updated Articles

Trending on OncLive

Pumitamig Plus Chemo Demonstrates Encouraging Efficacy in Frontline NSCLC

Oral Administration Afforded by CDK2 Inhibitors May Ease the Price of Admission in Platinum-Resistant Ovarian Cancer

MAIC Shows Improved PFS With Zanubrutinib Over Ibrutinib in Treatment-Naive CLL

Dr Randall on the Clinical Utility of Tumor-Informed ctDNA Deep Sequencing for Osteosarcoma Surveillance

Experts Weigh In on Some of the Most Impactful Data in Melanoma From ASCO 2026